Results 71 to 80 of about 58,092 (289)

Mediators and Cytokines in Persistent Allergic Rhinitis and Nonallergic Rhinitis with Eosinophilia Syndrome [PDF]

, 2012
Background: Patients with nonallergic rhinitis with eosinophilia syndrome (NARES) show typical symptoms of persistent allergic rhinitis (PAR). The aim of the present study was to compare nasal cytokine patterns between NARES and PAR.
Becker, Sven, Canis, Martin, Gröger, Moritz, Havel, Miriam, Klemens, Christine, Kramer, Matthias F., Pfrogner, Elisabeth, Rasp, Gerd, Wendt, Sebastian   +8 more
core   +1 more source

Leptin May Promote Eosinophilic CRSwNP Progression by Enhancing Eosinophil Chemotaxis and Angiogenesis Under a Type 2 Inflammatory Milieu

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyp (CRSwNP) is a heterogeneous Type 2 inflammatory disease characterized by enhanced eosinophilic infiltration. Both innate and adaptive immunity are involved in the onset and progression of CRSwNP.
Yuki Sonoda, Yohei Sato, Yoshimasa Imoto, Mayumi Tamari, Shigeharu Fujieda   +4 more
wiley   +1 more source

Staphylococcus aureus controls interleukin-5 release in upper airway inflammation [PDF]

, 2018
Staphylococcus aureus is a frequent colonizer of the upper airways in chronic rhinosinusitis with nasal polyps, but also resides intramucosally, it has been shown that secreted staphylococcal proteins such as enterotoxins and serine proteases induce the ...
Bachert, Claus, Bröker, BM, Gevaert, Elien, Holtappels, Gabriële, Merabishvili, Maia, Meyer, T, Murr, A, Schmidt, F, Van Crombruggen, Koen, Vaneechoutte, Mario, Völker, U, Zhang, Nan   +11 more
core   +2 more sources

Disease Remission: A Scoping Review With Thematic Analysis of the Scientific Literature With Implications for Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail, Lynn Warner, Stacey T. Gray, Claire Hopkins, Peter H. Hwang, Sarah K. Wise, Katie M. Phillips, Ahmad R. Sedaghat   +7 more
wiley   +1 more source

Fungi as Causative Agents of Nasal Polyps in Tehran, Iran [PDF]

Iranian Journal of Public Health, 2006
Nasal polyposis is an inflammatory condition of unknown etiology that involves nasal and sinus mucous membrane. These polyps can impair a person’s quality of life by nasal obstruction, recurrent sinusitis, persistent postnasal drainage, hyposmia, anosmia,
P Kordbacheh, F Zaini, A Sabokbar, H Borghei, M Safara   +4 more
doaj   +2 more sources

Nasal Dermoplasty for Recurrent Polyps in a Patient with Churg-Strauss Syndrome

Case Reports in Otolaryngology, 2015
Nasal dermoplasty for recurrent polyps (NDRP) is a new technique for the surgical treatment of this condition. Churg-Strauss syndrome is characterized by the presence of nasal polyps with a great tendency for relapse after surgical or pharmaceutical ...
George Anastasopoulos, Theophanis Machas, Sofia Kegioglou, Demetra Rapti   +3 more
doaj   +1 more source

Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps

Respiratory Research, 2009
Background Decreased infiltration of Foxp3+ T regulatory cell (Treg) is considered to be critical for the Th1/Th2 dysregulation of nasal polyps, while the cellular mechanism underlying Foxp3+ Treg insufficiency is currently not well defined.
Shi Jianbo, Cai Kemin, Liu Zheng, Yu Chuanzhao, Hua Xiaoyang, Zhou Han, Xia Jiahong, Xu Geng, Li Huabin   +8 more
doaj   +1 more source

Linking Complement C3 and B Cells in Nasal Polyposis

Journal of Immunology Research, 2020
Nasal polyposis often is characterized by a persistent inflammation of the sinonasal mucosa, disease recurrence after medical or surgical intervention, and asthma comorbidity.
Ulrike Werner, Axel Künstner, Maren Drenckhan, Ralph Pries, Karl-Ludwig Bruchhage, Hauke S. Busch, Claus Bachert, Barbara Wollenberg   +7 more
doaj   +1 more source

Nasal polyps. [PDF]

BMJ, 1973
  +9 more sources

Interleukin‐5, Eosinophils, and Interleukin‐5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, EarlyView.
Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley   +1 more source